Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT05752695
Enrolling by invitation Observational

Operation Korsband

NCT05752695 · tracked via the Priya Life Science Sweden tracker
Sponsor
Linnaeus University
Phase
Observational
Started
2023-09-01
Last updated
2025-12-30

Condition(s) studied

Anterior Cruciate Ligament Injuries

Study summary

This study aims to investigate if a detailed and comprehensive survey can identify, explain and prevent the risk factors for ACL injury.

A a new questionnaire has been developed with questions to young athletes who have suffered an anterior cruciate ligament injury. The questionnaire is more detailed and provide more information about how the anterior cruciate ligament injury occurred compared with the questionnaires currently available in the literature. This careful documentation will provide new knowledge and might be used to identify, explain and prevent risk factors that cause young athletes to suffer an anterior cruciate ligament injury.

Eligibility

Sex
ALL
Min age
12 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * Athlete * Defined ACL injury Exclusion Criteria: * Non athletes * Younger than 12 years

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sofia Ryman Augustsson Kalmar Sweden

More Linnaeus University trials in Sweden

Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial Recruiting
Exercise as Medicine: A Non-Pharmacological Approach to Menopausal Symptoms Recruiting
Sustainable Elite Football Enrolling by invitation
Operation ACL: Rehabilitation After Anterior Cruciate Ligament Reconstruction Starting soon
A Cluster-randomized Control Trial of PAX Good Behavior Game in Swedish Elementary Schools Recruiting

Other trials for the same condition

SEQUAR SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05752695 on ClinicalTrials.gov ↗ ← All trials in Sweden